85%Confidence
0Views
FDASource
2026-04-09Date
Summary
Strides Pharma's Class II recall for Children's Ibuprofen due to foreign particles indicates significant contamination issues, undermining trust in a common pediatric pain reliever marketed by Taro Pharmaceuticals. This could lead to increased parental caution and a shift toward alternative brands like Advil or Motrin for children's medications.
Actionable: Track consumer sentiment and sales data for children's ibuprofen brands to identify market shifts.
AI Confidence: 85%
Data Points
firmSTRIDES PHARMA INC
classificationClass II
statusOngoing
distributionU.S.A. Nationwide
productChildren's Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) bottle, Manufactured for: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now